Sonnet BioTherapeutics Holdings, Inc.
- May 16, 2018 · D · $1,411,249 sold of $1,411,249 · 13 investors · min. $10,500 · role: Executive Officer EDGAR ↗
- May 11, 2017 · D · $6,000,000 sold of $6,000,000 · 14 investors · min. $50,000 · role: Executive Officer EDGAR ↗
- Mar 18, 2015 · D · $1,000,000 sold of $1,000,000 · 1 investors · min. $25,000 · role: Executive Officer (Chief Financial Officer) EDGAR ↗
- Jan 16, 2015 · D · $1,150,000 sold of $1,150,000 · 12 investors · min. $25,000 · role: Executive Officer (Chief Financial Officer) EDGAR ↗
- Nov 20, 2013 · D · $800,000 sold of $800,000 · 3 investors · min. No minimum reported · role: Executive Officer (CFO) EDGAR ↗
- Oct 22, 2013 · D · $2,500,000 sold of $2,500,000 · 23 investors · min. $17,494 · role: Executive Officer (CFO) EDGAR ↗
- Oct 15, 2013 · D · $0 sold of Indefinite · 193 investors · min. No minimum reported · role: Executive Officer (CFO) EDGAR ↗
Raised $6M from 193 investors (100% of the $1.41M target) as of the latest filing. Eric is listed as executive officer on 7 filings for this deal.
Sources
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Restaurants / 506(b) (639 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.